Back

Future directions for research into LDL lowering, anti-inflammatory drugs and interactions.

26 August 2018 (17:21 - 17:33)
Organised by:
Congress Presentation Part of: LDL goals and inflammation. From basic science to clinical practice. Risk Factors and Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Sang-Hyun Kim

Seoul National University Boramae Hospital, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
New aspects of the patho-biology of atherosclerosis: the role of lipids and inflammation.
Professor A. Catapano (Milan, IT)
Presentation thumbnail
Current LDL-cholesterol goals- Are they appropriate?
Professor L. Tokgozoglu (Ankara, TR)
Presentation thumbnail
Identification of new molecule to mediate binding of PCSK9 and LDL-receptor - New insight on action mechanism of PCSK9 to degrade LDL-R
Doctor H. Kim (Seoul, KR)
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
LDL goals and inflammation. From basic science to clinical practice.

The Event

Event poster

ESC Congress 2018

26 August 2018 17:21 CET
You may be interested in
thumbnail
Congress Session
Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?
27 August 2022
thumbnail
Congress Presentation
Reduction of perivascular inflammation following long-term statin treatment - a coronary CT follow-up study using Fat Attenuation Index
25 August 2023
thumbnail
Congress Session
Targeting inflammation in cardiovascular diseases and pre-clinical models
29 August 2026
thumbnail
Congress Presentation
How to manage lipid risk pharmacologically – new approaches
13 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources